Feeling Tense
Background
Feeling tense is a common human experience characterized by a state of mental, emotional, or physical strain. It often arises as a natural response to stress, uncertainty, perceived threats, or challenging situations. This sensation can manifest in various ways, from subtle unease and restlessness to significant physical discomfort and heightened vigilance. While occasional tension is a normal part of life, persistent or intense feelings of tension can significantly impact an individual's well-being.
Biological Basis
The experience of tension is intricately linked to the body's physiological stress response systems. When an individual feels tense, the sympathetic nervous system often becomes activated, leading to a cascade of physical changes such as increased heart rate, muscle contraction, and altered breathing patterns. The hypothalamic-pituitary-adrenal (HPA) axis also plays a crucial role, releasing hormones like cortisol, which further modulates the body's response to stress. Neurotransmitters such as norepinephrine, serotonin, and gamma-aminobutyric acid (GABA) are key players in regulating mood, anxiety, and the perception of stress within the brain. Research indicates that genetic factors can influence an individual's predisposition to experiencing tension, affecting aspects like stress reactivity, the efficiency of neurotransmitter systems, and the structure and function of brain regions involved in emotional processing and threat assessment.
Clinical Relevance
While temporary tension is a normal and adaptive response, chronic or severe feelings of tension can have significant clinical implications. It is a hallmark symptom of various anxiety disorders, including Generalized Anxiety Disorder, Panic Disorder, and Social Anxiety Disorder. Moreover, persistent tension can contribute to the development or exacerbation of other mental health conditions, such as depression. Physically, chronic tension can manifest as headaches, muscle pain, digestive issues, sleep disturbances, and may even be associated with an increased risk of cardiovascular problems over time. Recognizing and addressing chronic tension is thus an important aspect of mental and physical health management.
Social Importance
The widespread prevalence of feeling tense in modern society has considerable social importance. It can impair an individual's ability to concentrate, make decisions, and interact effectively in social and professional settings, thereby impacting productivity and interpersonal relationships. High levels of chronic tension across a population can contribute to a significant public health burden, necessitating resources for mental health support and stress management programs. Understanding the biological and genetic underpinnings of tension is crucial for developing more effective prevention strategies, early diagnostic tools, and targeted interventions aimed at alleviating this pervasive human experience and improving overall quality of life.
Methodological and Statistical Constraints
Genome-wide association studies (GWAS) often face limitations related to statistical power and study design, which can influence the detection and interpretation of genetic associations. Many investigations, even when using moderate-sized community-based samples, acknowledge limited statistical power to detect modest genetic effects, especially given the extensive multiple testing required for genome-wide screens. [1] This constraint means that genetic variants with smaller effect sizes, which are common for complex traits, may not reach statistical significance and thus remain undetected. [1] Consequently, while the absence of genome-wide significance does not preclude a genetic influence, it highlights the challenge in capturing the full spectrum of genetic contributions to traits like feeling tense.
Replication in independent cohorts is crucial for validating initial GWAS findings, yet non-replication is a common challenge. Differences in study power and design between investigations can account for failures to replicate previously reported associations. [2] Moreover, non-replication at the single nucleotide polymorphism (SNP) level can occur if different studies identify distinct SNPs that are in strong linkage disequilibrium with an underlying causal variant but not with one another, or if multiple causal variants exist within the same gene region. [2] Furthermore, the use of specific SNP arrays, such as the Affymetrix 100K GeneChip, means that not all genetic variation across the genome is comprehensively covered, potentially leading to missed associations due to insufficient SNP density in certain gene regions. [3] While imputation methods can infer missing genotypes, varying marker sets across studies and inherent imputation error rates (e.g., 1.46% to 2.14% per allele) can introduce uncertainty and affect the comparability of results across different cohorts. [4]
Phenotype Definition and Generalizability
The accurate and consistent measurement of complex phenotypes like feeling tense presents a significant challenge in genetic studies. When traits are averaged across multiple examinations spanning extended periods, such as twenty years, it can mask age-dependent gene effects and introduce misclassification due to changes in measurement equipment over time. [1] Additionally, environmental or physiological factors, such as the time of day blood samples are collected, can influence phenotype measurements and potentially confound genetic associations if not consistently controlled across all participants. [5] Such methodological variability in phenotype ascertainment can complicate the identification of robust genetic signals.
Generalizability of findings is a key concern, as many GWAS are predominantly conducted in populations of European descent. [1] This demographic bias limits the direct applicability of identified genetic associations to other ethnicities, where genetic architectures and environmental exposures may differ significantly. [1] Furthermore, studies relying on specific cohorts, such as volunteer participants or twins, may introduce a degree of selection bias compared to a truly random sample from the general population. [5] While such biases are often considered to have a minimal impact on SNP-phenotype associations for many traits, they can still influence the broader representativeness of the findings. Lastly, the practice of performing only sex-pooled analyses to manage the burden of multiple testing means that genetic variants exclusively associated with a phenotype in either males or females may remain undetected, potentially overlooking important sex-specific genetic influences. [3]
Environmental Interactions and Unexplained Heritability
The etiology of complex traits like feeling tense is highly intricate, involving a dynamic interplay between genetic predispositions and environmental factors. Genetic variants often influence phenotypes in a context-specific manner, with their effects being modulated by various environmental influences. [1] The absence of comprehensive investigations into these gene-environment interactions means that current studies may not fully capture the complex genetic architecture of the trait, as environmental factors could significantly alter how genetic predispositions manifest. [1] Therefore, a complete understanding requires moving beyond main genetic effects to explore these intricate interactions.
Despite the successes of GWAS in identifying numerous genetic loci, a substantial portion of the heritability for many complex traits, including those related to psychological states, remains unexplained by common SNPs. This phenomenon, often referred to as "missing heritability," suggests that many genetic effects are individually small, or involve rare variants, structural variations, or complex epistatic interactions that are not adequately captured by current GWAS methodologies. While efforts are made to account for population substructure through methods like genomic control and principal component analysis, residual stratification within seemingly homogenous populations can still potentially confound association analyses, leading to spurious findings if not perfectly addressed. [6] Addressing these remaining knowledge gaps will require larger, more diverse cohorts and advanced analytical approaches that can untangle these complex genetic and environmental contributions.
Variants
Genetic variations across several loci can influence neurobiological pathways and cellular functions, potentially contributing to an individual's predisposition to feeling tense. These variants span genes involved in neural development, synaptic communication, gene regulation, and metabolic processes.
Genes like FOXP2, essential for the development of speech and language, and NCAM1 (Neural Cell Adhesion Molecule 1), critical for neural plasticity and learning, play significant roles in brain function. Alterations in FOXP2, such as those potentially associated with rs1450832, can impact cognitive and motor learning circuits, indirectly affecting an individual's capacity to manage stress or communicate effectively, which may manifest as feelings of tension. [7] Similarly, a variant like rs4937872 near NCAM1 could influence the brain's adaptability to stress and emotional processing. TSNARE1 is involved in synaptic vesicle trafficking and neurotransmitter release, fundamental for neuronal communication, and variations like rs4129585 might subtly alter synaptic efficiency, affecting mood regulation. [8] Furthermore, TMEM106B (rs11509880) is implicated in lysosomal function and neurodegeneration, both crucial for maintaining neuronal health and resilience against stressors that could contribute to a tense state.
Other variants affect genes involved in transcriptional regulation and cellular metabolism. RERE, a transcriptional coregulator, influences various developmental processes, and changes linked to rs2100888 could disrupt the precise control of gene expression necessary for cellular homeostasis and stress response. [9] ZC3H7B, a zinc finger protein, is involved in RNA binding and gene expression regulation; a variant like rs11090045 might alter RNA stability or translation, subtly impacting pathways related to stress or neurotransmission. The arsenic methyltransferase (AS3MT) gene and the related BORCS7-ASMT locus, represented by rs3740393, are known for their roles in detoxification and methylation processes. [3] Variations in this region could influence metabolic efficiency, potentially affecting the body's ability to manage systemic stress, which can manifest as increased tension.
Long intergenic non-coding RNAs (lncRNAs), such as LINC02763 (rs4937872), LINC02758 (rs10767733), LINC02488 (rs28738966), and LINC01122 (rs4671330), are emerging as key regulators of gene expression, chromatin structure, and various cellular activities. While their specific functions are still under investigation, lncRNAs are known to influence brain development and function, making their variants relevant to neuropsychiatric traits. [10] For example, LINC02763 is located near NCAM1, suggesting a potential regulatory link that could impact neural cell adhesion and plasticity. METTL15, a methyltransferase, and TMEM161B, a transmembrane protein, are associated with LINC02758 and LINC02488 respectively, indicating that these lncRNAs may regulate the function of these nearby protein-coding genes. [11] Dysregulation of these lncRNAs or their associated genes could lead to subtle neurological imbalances, potentially contributing to an individual's susceptibility to experiencing feelings of tension or anxiety.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs4937872 | LINC02763 - NCAM1 | feeling tense measurement post-traumatic stress disorder anxiety measurement coffee consumption measurement, major depressive disorder irritable bowel syndrome |
| rs11090045 | ZC3H7B | neuroticism measurement feeling nervous measurement feeling tense measurement smoking cessation neurotic disorder |
| rs10767733 | METTL15 - LINC02758 | feeling tense measurement |
| rs28738966 | LINC02488 - TMEM161B | feeling tense measurement |
| rs4671330 | LINC01122 | feeling tense measurement |
| rs4129585 | TSNARE1 | feeling nervous measurement feeling tense measurement schizophrenia obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder autism spectrum disorder, schizophrenia |
| rs2100888 | RERE | feeling tense measurement |
| rs11509880 | TMEM106B | coronary artery disease neuroticism measurement mood instability measurement feeling tense measurement neurotic disorder |
| rs1450832 | FOXP2 | conotruncal heart malformations congenital heart disease feeling tense measurement |
| rs3740393 | AS3MT, BORCS7-ASMT | Moderate albuminuria feeling tense measurement cortical thickness neuroticism measurement anxiety |
Causes
Feeling tense is a complex trait influenced by an interplay of genetic predispositions, environmental factors, developmental experiences, and co-occurring health conditions. Research into the underlying causes often involves large-scale genetic and epidemiological studies to identify contributing factors.
Genetic and Neurobiological Underpinnings
Genetic factors contribute significantly to an individual's susceptibility to feeling tense, often through pathways linked to conditions like anxiety and depression. Studies specifically investigate the "Genetic basis of anxiety and depression," indicating a recognized inherited component to these states, which frequently manifest as feelings of tension. [12] While specific genetic loci for feeling tense might not always achieve genome-wide significance in initial screenings, this does not preclude a substantial role for genetic influences on such traits. [1] The genetic architecture is typically polygenic, meaning numerous common genetic variants, each with a small effect, collectively increase an individual's predisposition.
Further, the heritability of traits related to psychological well-being is often substantial, with estimates for various complex traits suggesting that genetic factors account for a significant portion of their variability. [2] Despite this, many specific genetic loci contributing to this heritability remain undiscovered, implying the existence of additional common variants, potentially with even smaller effects, or variants whose effects are dependent on interactions with environmental factors. [2] This points to a complex genetic landscape underlying the biological systems that regulate mood and stress responses.
Environmental and Lifestyle Influences
Environmental factors play a crucial role in the development and manifestation of feeling tense, encompassing a range of external exposures and lifestyle choices. Lifestyle, diet, and general environmental exposures are often collected through detailed questionnaires in population studies, acknowledging their importance in health outcomes. [12] These factors can include daily stressors, social interactions, and physical activity levels, all of which can modulate an individual's experience of tension.
Geographic and socioeconomic factors can also contribute to feelings of tension. Community-based studies, such as those conducted in specific European populations, highlight how the unique characteristics of a locale, including its socioeconomic environment, can influence various health and psychological traits. [12] Such influences underscore how the broader social and physical environment interacts with individual vulnerabilities to shape one's overall state of well-being.
Developmental Factors and Gene-Environment Interactions
Early life experiences and developmental trajectories significantly shape an individual's predisposition to feeling tense later in life. Birth cohort studies, which track individuals from birth through adulthood, provide insights into how events and exposures during critical developmental periods can influence long-term physiological and psychological outcomes. [2] These early influences can program stress responses and coping mechanisms, thereby affecting an individual's baseline level of tension.
The interplay between genetic predispositions and environmental triggers, known as gene-environment interactions, is also critical. Genetic vulnerabilities for feeling tense are often not expressed in isolation but are rather modulated by specific environmental variables. [2] For instance, a genetic tendency towards anxiety might only manifest as significant tension under conditions of chronic stress or specific adverse experiences. This complex interaction suggests that both inherited factors and life experiences are essential in determining an individual's susceptibility to and expression of tension.
Comorbidities and Physiological Contributors
Feeling tense frequently co-occurs with, or is a symptom of, other medical and psychological conditions, thereby linking its causes to a broader spectrum of health issues. It is often a prominent feature of anxiety and depression, both of which are subjects of extensive genetic and epidemiological research. [12] Furthermore, feeling tense can be exacerbated by or associated with various physiological conditions.
Cardiovascular diseases, high blood pressure, and metabolic disorders, which are often investigated in large cohort studies, can indirectly contribute to or intensify feelings of tension. [1] Medication effects, particularly those used to manage these chronic conditions, may also influence an individual's emotional state. Additionally, age-related physiological changes can alter how individuals experience and cope with tension, suggesting that the expression and impact of tension can vary significantly across the lifespan . [1], [2]
Biological Background
The sensation of "feeling tense" can stem from a complex interplay of molecular, cellular, and systemic physiological processes that regulate the body's internal state and responsiveness to stimuli. These biological mechanisms involve various signaling pathways, genetic predispositions, and homeostatic controls across different tissues and organs, particularly within the cardiovascular and muscular systems, and through systemic metabolic and inflammatory responses.
Vascular and Neurohormonal Regulation
The body maintains vascular tone and blood pressure through an intricate system involving key biomolecules and cellular pathways. For instance, phosphodiesterase 5 (PDE5) plays a critical role in regulating vascular smooth muscle contraction by degrading cyclic guanosine monophosphate (cGMP), thereby maintaining a contracted state of blood vessels. Angiotensin II, a potent vasoconstrictor, can further influence this by increasing the expression of PDE5A in vascular smooth muscle cells, which antagonizes cGMP signaling and contributes to the growth-promoting effects of Angiotensin II on these cells.. [13] This mechanism is fundamental to the body's control over blood flow and pressure, which can contribute to a state of physiological tension.
Beyond direct contraction, the health of the vascular endothelium is crucial for systemic regulation. Endothelial dysfunction, often assessed via brachial artery flow-mediated dilation (FMD), is recognized as a precursor to cardiovascular disease. The enzyme endothelial nitric oxide synthase (eNOS) is vital for producing nitric oxide, a powerful vasodilator that relaxes blood vessels. Genetic variations, such as common polymorphisms at the eNOS locus, have been linked to individual differences in brachial artery vasodilator function, highlighting how genetic factors can influence the body's capacity for vascular relaxation and its susceptibility to conditions like high blood pressure.. [1]
Cellular Signaling and Tissue Mechanics
Cellular mechanisms contribute directly to the mechanical properties and responsiveness of tissues, which can underlie sensations of tension. The CFTR (cystic fibrosis transmembrane conductance regulator) chloride channel, for example, is expressed in human endothelia, where its activity is essential for various cellular functions.. [14] The integrity and proper functioning of such channels are critical for cellular homeostasis.
Further research indicates that disruption of the CFTR chloride channel can alter the mechanical properties and cAMP-dependent chloride transport in mouse aortic smooth muscle cells.. [15] This suggests that defects or modulations in specific cellular ion channels can directly impact the contractile and mechanical characteristics of smooth muscle tissues, including those in the vasculature, potentially contributing to altered tissue tension.
Genetic Contributions to Physiological Adaptations
Individual differences in physiological responses, including those related to cardiovascular function and exercise, are influenced by genetic factors. Traits such as echocardiographic dimensions, brachial artery endothelial function, and treadmill exercise responses are known to be heritable. Genetic variations, including polymorphisms in the renin-angiotensin system (e.g., the ACE gene) and the eNOS locus, have been associated with endothelium-dependent vasodilation and the acute blood pressure response to aerobic exercise.. [1] These genetic predispositions can shape an individual's baseline physiological state and their reactivity to physical or environmental stressors.
Moreover, specific gene polymorphisms can influence complex physiological adaptations. For instance, a polymorphism in the acetylcholine receptor M2 (CHRM2) gene has been linked to heart rate recovery after maximal exercise, reflecting autonomic nervous system regulation.. [16] Beyond direct physiological responses, genetic factors also impact metabolic pathways; common single nucleotide polymorphisms (SNPs) in the HMGCR gene, for example, affect the alternative splicing of exon 13, which in turn influences low-density lipoprotein (LDL) cholesterol levels.. [17] Such genetic variations collectively contribute to the individual's overall physiological profile, including their propensity for experiencing states of tension.
Systemic Biomarkers and Inflammatory Responses
The body's systemic state, influenced by metabolic and inflammatory processes, can significantly contribute to overall physiological well-being and sensations of tension. Various circulating biomarkers provide insights into these systemic conditions. Inflammatory markers, such as CD40 ligand, osteoprotegerin, P-selectin, tumor necrosis factor receptor 2, and tumor necrosis factor-α, are routinely measured and reflect levels of systemic inflammation and oxidative stress.. [7] Chronic or elevated inflammation can manifest as generalized discomfort or a feeling of being "tense" throughout the body.
Beyond inflammation, metabolic parameters and vitamin status are crucial for maintaining homeostasis. Plasma levels of natriuretic peptides, vitamin K (phylloquinone), and vitamin D (25(OH)D) are important indicators of cardiovascular and bone health, respectively. Additionally, liver enzymes like aspartate aminotransferase and alanine aminotransferase, along with lipid profiles (total cholesterol, HDL, triglycerides), glucose, and insulin concentrations, reflect metabolic function.. [7] Disruptions in these homeostatic balances, whether due to inflammation or metabolic dysregulation, can lead to systemic physiological alterations that contribute to a generalized feeling of tension or malaise.
Neuro-Cardiovascular Signaling and Receptor Dynamics
The sensation of tension can be intricately linked to the activation of various neuro-cardiovascular signaling pathways that regulate vascular tone and cardiac function. For instance, the MAPK pathway, whose activation is influenced by factors like age and acute exercise, plays a critical role in cellular responses, including those in skeletal muscle and potentially contributing to systemic physiological states ([18] ). Furthermore, Angiotensin II signaling can influence vascular smooth muscle cells by increasing the expression of phosphodiesterase 5A, thereby antagonizing cGMP signaling and affecting vasoregulation ([13] ). The mechanical properties and ion transport in vascular smooth muscle cells are also modulated by channels like the CFTR chloride channel, whose disruption can alter cAMP-dependent Cl-transport, impacting overall cardiovascular responsiveness ([15] ).
Beyond direct vascular effects, neuronal chemorepellents like Slit2 can inhibit vascular smooth muscle cell migration by suppressing small GTPase Rac1 activation, highlighting the complex interplay between neuronal guidance cues and cardiovascular cell behavior ([19] ). Cardiac excitability and contractility are critically dependent on calcium handling, with ryanodine receptor channels being central. Dysregulation or mutations in the cardiac Ryanodine Receptor Gene (hRyR2) can lead to channelopathies, such as catecholaminergic poly-ventricular tachycardia, demonstrating a direct molecular link to potentially profound physiological disturbances that could manifest as or contribute to a state of tension ([20], [21] ).
Metabolic Homeostasis and Lipid Regulation
Metabolic pathways, particularly those governing energy metabolism and lipid homeostasis, are fundamental to maintaining physiological balance and can contribute to states of tension when dysregulated. The mevalonate pathway, crucial for cholesterol biosynthesis, is a key metabolic cascade that is tightly regulated ([22] ). Genetic variants, such as common single nucleotide polymorphisms (SNPs) in HMGCR, can influence LDL-cholesterol levels by affecting alternative splicing of exon13, thereby impacting lipid metabolism ([17] ).
Lipid-regulating proteins like ANGPTL3 and ANGPTL4 also play significant roles, with ANGPTL3 regulating overall lipid metabolism and variations in ANGPTL4 being associated with reduced triglycerides and increased HDL levels ([23], [24] ). The transcription factor SREBP-2 provides a regulatory link between isoprenoid and adenosylcobalamin metabolism, demonstrating the interconnectedness of various metabolic processes ([25] ). Furthermore, the enzyme hexokinase (HK1), involved in glycolysis, has been associated with glycated hemoglobin levels in non-diabetic populations, underscoring the importance of glucose metabolism and its potential for abnormalities in erythrocyte enzyme function ([6], [26] ).
Gene Expression and Post-Translational Control
The intricate regulation of gene expression and subsequent protein modification forms a critical layer of control over physiological responses, including those that influence feelings of tension. Transcription factor regulation, such as the SREBP-2 pathway, directly governs the expression of genes involved in lipid and isoprenoid metabolism, thereby impacting the availability of crucial cellular components ([25] ). Post-translational modifications, like the phosphorylation events that characterize MAPK cascades, are also under tight control, with protein families such as the human tribbles acting as regulators of these cascades ([27] ).
Moreover, gene regulation extends to the precise control of protein variants through mechanisms like alternative splicing, as seen with HMGCR, where common SNPs can influence the splicing of exon13 and thus affect LDL-cholesterol levels ([17] ). The expression of key enzymes, such as phosphodiesterase 5A, is also regulated at the transcriptional level, with Angiotensin II specifically increasing its expression in vascular smooth muscle cells, illustrating a feedback loop where external signals modulate intracellular signaling components ([13] ). This multi-layered regulation ensures precise control over cellular function, with dysregulation at any point potentially contributing to an altered physiological state.
Systemic Interconnections and Network Crosstalk
Physiological states, including 'feeling tense', arise from the complex integration and crosstalk among various biological pathways and organ systems. For example, the parallel gene expression of IL-6 and BNP during cardiac hypertrophy, particularly when complicated by diastolic dysfunction in hypertensive rats, illustrates a network interaction where inflammatory and cardiac stress markers are co-regulated ([28] ). This highlights how systemic responses to stress or disease involve coordinated changes across multiple molecular pathways.
The study of metabolomics, which provides a comprehensive measurement of endogenous metabolites, serves as a powerful platform for understanding drug toxicity, gene function, and identifying distinct metabolic phenotypes in humans ([29], [30] ). This systems-level approach allows for the direct mapping of quantitative trait loci to mammalian metabolic phenotypes, revealing how genetic variations propagate through metabolic networks to influence observable traits ([31] ). Such network interactions and hierarchical regulation demonstrate that the feeling of tension is an emergent property of integrated physiological responses, where changes in one system can cascade and influence others.
Dysregulation in Cardiovascular and Metabolic Health
Dysregulation within these intricate pathways and mechanisms can lead to various disease states, and understanding these can offer insights into the physiological underpinnings of 'feeling tense'. Conditions such as hypertension and cardiac hypertrophy are associated with altered gene expression, including heat shock proteins, which are critical for cellular protection against stress ([32] ). These disease-relevant mechanisms represent a breakdown in the normal regulatory processes that maintain cardiovascular stability.
Metabolic disorders, including dyslipidemia and abnormalities in glucose metabolism, also represent pathway dysregulation with systemic consequences. For instance, the association of HK1 with glycated hemoglobin in non-diabetic individuals points to subtle metabolic shifts that could be indicative of underlying stress on energy homeostasis ([6] ). The identification of specific gene mutations, like those in the cardiac Ryanodine Receptor Gene, that lead to catecholaminergic poly-ventricular tachycardia, provides clear examples of how molecular dysfunctions can manifest as severe physiological conditions ([21] ). These insights into pathway dysregulation and compensatory mechanisms are crucial for identifying potential therapeutic targets aimed at restoring physiological balance.
References
[1] Vasan, R. S., et al. "Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study." BMC Med Genet, 2007.
[2] Sabatti, C., et al. "Genome-wide association analysis of metabolic traits in a birth cohort from a founder population." Nat Genet, 2008.
[3] Yang, Q., et al. "Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study." BMC Med Genet, 2007.
[4] Willer, C. J., et al. "Newly identified loci that influence lipid concentrations and risk of coronary artery disease." Nat Genet, 2008.
[5] Benyamin, B., et al. "Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels." Am J Hum Genet, 2009.
[6] Pare, G. et al. "Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study." PLoS Genet, 2008.
[7] Benjamin, E. J., et al. "Genome-wide association with select biomarker traits in the Framingham Heart Study." BMC Med Genet, 2007.
[8] Wilk, J. B., et al. "Framingham Heart Study genome-wide association: results for pulmonary function measures." BMC Med Genet, vol. 8, 2007, p. S8. PMID: 17903307.
[9] Kathiresan, S., et al. "Common variants at 30 loci contribute to polygenic dyslipidemia." Nat Genet, vol. 41, no. 5, 2009, pp. 560-565. PMID: 19060906.
[10] Reiner, A. P., et al. "Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein." Am J Hum Genet, vol. 82, no. 5, 2008, pp. 1193-1200. PMID: 18439552.
[11] Melzer, D., et al. "A genome-wide association study identifies protein quantitative trait loci (pQTLs)." PLoS Genet, vol. 4, no. 5, 2008, e1000072. PMID: 18464913.
[12] Aulchenko, Y. S., et al. "Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts." Nature Genetics, 2008.
[13] Kim, D. et al. "Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling." J Mol Cell Cardiol, vol. 38, 2005, pp. 175-184.
[14] Tousson, A., et al. "Characterization of CFTR expression and chloride channel activity in human endothelia." American Journal of Physiology-Cell Physiology, vol. 275, no. 6, 1998, pp. C1555-C1564.
[15] Robert, R. et al. "Disruption of CFTR chloride channel alters mechanical properties and cAMP-dependent Cl-transport of mouse aortic smooth muscle cells." J Physiol (Lond), vol. 568, 2005, pp. 483-495.
[16] Hautala, Arto J., et al. "Heart rate recovery after maximal exercise is associated with acetylcholine receptor M2 (CHRM2) gene polymorphism." American Journal of Physiology-Heart and Circulatory Physiology, vol. 291, no. 2, 2006, pp. H459-H466.
[17] Burkhardt, R. et al. "Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13." Arterioscler Thromb Vasc Biol, 2009.
[18] Vasan, R. S. "activated protein kinase (MAPK) pathway activation: effects of age and acute exercise on human skeletal muscle." J Physiol, vol. 547, 2003, pp. 977-987.
[19] Liu, D. et al. "Neuronal chemorepellent Slit2 inhibits vascular smooth muscle cell migration by suppressing small GTPase Rac1 activation." Circ Res, vol. 98, 2006, pp. 480-489.
[20] Benkusky, N. A. et al. "Ryanodine receptor channelopathies." Biochem Biophys Res Commun, vol. 322, 2004, pp. 1280-1285.
[21] Priori, S. G. et al. "Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Poly-Ventricular Tachycardia." Circulation, vol. 103, 2002, pp. 196-200.
[22] Goldstein, J. L. et al. "Regulation of the mevalonate pathway." Nature, vol. 343, 1990, pp. 425–430.
[23] Koishi, R. et al. "Angptl3 regulates lipid metabolism in mice." Nat Genet, vol. 30, 2002, pp. 151–157.
[24] Romeo, S. et al. "Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL." Nat Genet, vol. 39, 2007, pp. 513–516.
[25] Murphy, C. et al. "Regulation by SREBP-2 defines a potential link between isoprenoid and adenosylcobalamin metabolism." Biochem Biophys Res Commun, vol. 355, 2007, pp. 359–364.
[26] van Wijk, R. et al. "The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis." Blood, vol. 106, 2005, pp. 4034–4042.
[27] Kiss-Toth, E. et al. "Human tribbles, a protein family controlling mitogen-activated protein kinase cascades." J Biol Chem, vol. 279, 2004, pp. 42703–42708.
[28] Haugen, E. et al. "Parallel gene expressions of IL-6 and BNP during cardiac hypertrophy complicated with diastolic dysfunction in spontaneously hypertensive rats." Int J Cardiol, 2006.
[29] Assfalg, M. et al. "Evidence of different metabolic phenotypes in humans." Proc Natl Acad Sci U S A, vol. 105, 2008, pp. 1420–1424.
[30] Nicholson, J. K. et al. "Metabonomics: a platform for studying drug toxicity and gene function." Nat Rev Drug Discov, vol. 1, 2002.
[31] Dumas, M. E. et al. "Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models." Nat Genet, vol. 39, 2007, pp. 666–672.
[32] Iwabuchi, K. et al. "Heat shock protein expression in hearts hypertrophied by genetic and nongenetic hypertension." Heart Vessels, vol. 13, 1998, pp. 30-39.